↓ Skip to main content

Effectiveness and Tolerability of Anlotinib Plus PD-1 Inhibitors for Patients with Previously Treated Metastatic Soft-Tissue Sarcoma

Overview of attention for article published in International Journal of General Medicine, September 2022
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effectiveness and Tolerability of Anlotinib Plus PD-1 Inhibitors for Patients with Previously Treated Metastatic Soft-Tissue Sarcoma
Published in
International Journal of General Medicine, September 2022
DOI 10.2147/ijgm.s379269
Pubmed ID
Authors

Xin Sun, Jie Xu, Lu Xie, Wei Guo